ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (3): 264-269.DOI: 10.3969/j.issn.1006-298X.2026.03.013

• 肾脏病基础 • 上一篇    下一篇

乳酸化修饰与肾脏疾病

  

  • 出版日期:2026-06-29 发布日期:2026-07-02

Lactylation modification and kidney diseases

  • Online:2026-06-29 Published:2026-07-02

摘要: 近年来,乳酸化修饰作为一种新型蛋白质翻译后修饰方式备受关注。该修饰广泛存在于组蛋白、信号分子、功能酶及代谢底物相关蛋白,在疾病的发生发展中发挥重要的调控作用。现有研究证实,乳酸化修饰在肾脏疾病中具有关键的病理生理学意义。本文综述了乳酸的生理功能及其与肾脏代谢的关联机制,系统分析了乳酸分子及乳酸化修饰在急性肾损伤与慢性肾脏病发生发展中的调控作用,并提出靶向调控乳酸代谢通路可能成为肾疾病治疗的潜在策略,以期为后续相关研究提供理论依据。

关键词: 乳酸化修饰, 乳酸, 肾脏疾病

Abstract: Lactylation modification, a novel form of post-translational modification, has garnered significant attention in recent years. This modification is prevalent in histones, signaling molecules, functional enzymes, and proteins associated with metabolic substrates, playing a crucial regulatory role in the onset and progression of diseases. Existing research has established the pathophysiological significance of lactylation modification in kidney diseases. This article reviews the physiological functions of lactate and its mechanistic association with kidney metabolism, systematically analyzing the regulatory roles of lactate molecules and lactylation modification in the development of acute kidney injury (AKI) and chronic kidney disease (CKD). Furthermore, it proposes that targeting the regulation of lactate metabolic pathways may emerge as a potential strategy for the treatment of kidney diseases, thereby providing theoretical foundations and directional insights for subsequent related research.

Key words: lactylation modification, lactic acid, kidney diseases

中图分类号: